Version 1: Horizantal scroll

Executive Committee Member - Steven Bukvic - Chairman, Exec. Committee, ACROSS

Steven Bukvic

Chairman, Executive Committee, ACROSS Global
Executive Committee Member - Dr. Jawad Gill - CEO, ORCI Trials

Dr. Jawad Gill

CEO, ORCI Trials
Executive Committee Member - Denise McNerney - Partner, GLSA

Denise McNerney

Partner, GLSA
Executive Committee Member - Charles Oviawe - Managing Partner, Guosa Life Sciences

Charles Oviawe

Managing Partner, Guosa Life Sciences
Executive Committee Member - Georges Labaki - CEO, Phoenix Clinical Research, Co-Founder - Balsam

Georges Labaki

CEO, Phoenix Clinical Research, Co-Founder - Balsam
Executive Committee Member - Kálmán Törőcsik - COO, Research Professionals

Kálmán Törőcsik

COO, Research Professionals
Executive Committee Member - Mariano Monteagudo - Business Development Director, ACTIVA

Mariano Monteagudo

Business Development Director, ACTIVA
Nikola CIhoric - Founder - Wemedoo oomnia

Nikola Cihoric

Founder, Wemedoo AG

Version 2: Carousel

Accelerate
Your Clinical Trials

Unlock the power of global reach with tailored solutions designed to streamline your clinical trials, reduce costs, and deliver results faster

Steven Bukvic

Steven Bukvic graduated from Coventry University in 1982 with a degree in Applied Biology. After serving in the commercial sector of the UK motor industry for 8 years, Steven joined the Pharmaceutical Industry in 1990. For the next 27 years Steven’s career in the Pharmaceutical / CRO sectors has covered a broad range of disciplines within the field of clinical research, including clinical site monitoring, project management, pharmacovigilance, training, quality assurance and business operations. Steven has worked in Covance, GSK, MSD and Pfizer to name just a few of the multi-national companies in his career. Steven was instrumental in establishing a CRO in Asia as well as successfully building a number of CRO partnerships. He has also had extensive geographical exposure having worked in the UK, US, Germany, China and the Russian Federation.

Dr. Jawad Gill

Dr Gill brings over 27 years of experience at leading Pharma companies and CROs across Pakistan, APAC, AME, and CIS. He is a medical graduate, and his expertise covers several facets of clinical research including Clinical Operations, Quality Assurance & Compliance, Medical Monitoring, and Training. Over his career, he has successfully led global teams in various functions.

Dr Gill brings over 27 years of experience at leading Pharma companies and CROs across Pakistan, APAC, AME, and CIS. He is a medical graduate, and his expertise covers several facets of clinical research including Clinical Operations, Quality Assurance & Compliance, Medical Monitoring, and Training. Over his career, he has successfully led global teams in various functions.

Eventually he moved on to GSK Singapore as Clinical Research, Quality and Training Manager, where he managed teams across Asia-Pacific, Middle East, Africa, and Central Asian regions. During this time, he developed, trained, and led Clinical Operations country teams in Singapore, Malaysia, and Vietnam.

In his most recent role at Fortrea (previously known as Covance) Singapore, as Head of Clinical QA&C he managed Southeast Asia, Japan, South Korea, Australia, and New Zealand, leading a team of auditors conducting Investigator Site Audits, Process Audits, Vendor Qualification Audits, and supporting Client Audits and Regulatory Inspections.

Dr Gill has held leadership positions in various functions, organizations, and regions and has developed, trained, and led several teams simultaneously. Overall, he has been actively involved in more than 150 clinical studies with different phases, designs, and complexities. He has conducted trainings for clinical research professionals and investigators in Pakistan, China, Taiwan, Philippines, S. Korea, S. Africa, Thailand, Vietnam, Turkey and several other countries. He has been involved in the formulation of clinical research guidelines and regulations in some developing countries.

Denise McNerney

With over 25 years of expertise in Business, Marketing, and Technology within the life sciences industry, Denise is a seasoned professional. Her entrepreneurial drive, coupled with vast knowledge and resources, has fueled the creation of multiple successful businesses, streamlined processes, and fostered cohesive teams. Throughout her career, Denise has been instrumental in the launch of innovative products and services, effectively reaching targeted audiences. Building on a foundation of trust, she has cultivated enduring business relationships.

As a Partner at Global Life Sciences Alliance, Denise channels her skills into business development, strategy, and operations. Beyond her professional endeavors, Denise finds joy in volunteering for nonprofits, mentoring individuals and advising startup companies. An avid traveler and enthusiast of an active lifestyle, she embraces diverse experiences in both her personal and professional spheres.

Charles Oviawe

Charles is a Quality Assurance professional with over 20 year’s experience in Quality Systems Development and Management with emphasis on the United States Food and Drug Administration, ICH and global requirements for Good Clinical Practices, Good Laboratory Practice for Nonclinical Laboratory Studies, Good Pharmacovigilance Practices, Clinical Laboratory Improvement Amendments, current Good Manufacturing Practices and Computer System Validation.

Georges Labaki

Georges Labaki obtained his Pharm D in 2000 from Saint Joseph University in Lebanon. In addition, he holds a Master’s Degree in Cardiovascular Pharmacology from Claude-Bernard University, Lyon, France and an executive MBA from Ecole Supérieure des Affaires, Lebanon. Dr Labaki developed 18 years of professional experience in clinical research from big pharmaceutical companies and CROs in Lebanon and Switzerland, such as Merck Serono, Sanofi, Quintiles Outcome and ClinTec International.

Starting October 2012, Dr Labaki became the Chief Executive Officer of his own Clinical Research Organization (CRO): Phoenix Clinical Research (Phoenix CR); with main focus on the Middle East and North Africa region.

He is also the Co-Founder of Balsam Clinical Research, that started operations in Saudi Arabia in October 2021.

Kálmán Törőcsik

Kálmán Törőcsik graduated from University of Szeged in 2005 as doctor of medicine. Since his graduation Kálmán serves the Pharmaceutical Industry. Working with different Pharmaceutical and CRO companies like Amgen, Allergan, Pfizer and Chiltern Kalman collected experience on several fields of clinical research operation as CRA and project manager. Starting March 2014, as a joint partner, Kalman became the Chief Operating Officer of Research Professionals Ltd., a Hungarian CRO with main focus on Central European Region. In this position his is responsible for conducting of clinical trials and home care services in the region.

Mariano Monteagudo

With over 14 years of experience in pharmacology and clinical research, he currently leads the business development and customer relations efforts at Activa-CRO, focused on finding the best solution for project success from regulatory, operational and financial perspectives. Mr. Monteagudo received both his Pharmacist and MBA at Pontificia Universidad Catòlica (UCA) Buenos Aires, ARG, and has held a range of positions of increasing responsibility in the CRO industry, including experience in Quintiles, Merck Sharpe & Dohme Laboratory (MSD), GSK Pharmaceutical, MDS Pharma Services, MDS Pharma Services, INC Research and I3. Joining Activa in 2013, he worked as CTM as well as interacting with clinical operation planning and customer relations with Biotechs, Pharmaceutical company and CROS and his new position since 2015 as Director Business Development Strategy in which he acts as primary contact of client from US, Europe and Asia due in order to develop and stablish a project in the following Latin America countries: Argentina, Chile, Uruguay, Brazil, Peru, Colombia, Panama, Ecuador and Mexico.

Nikola Cihoric

Nikola is the founder and the innovative mind behind Wemedoo AG.

With over 15 years of experience in radiation oncology at Switzerland’s largest university hospital, he has garnered a reputation as a visionary in the industry. Nikola’s involvement in various international working groups, such as mCODE, CodeX, HL7/FHIR, CDISC, and DIA Europe, reflects his dedication to advancing clinical data standards, driving innovation, and ensuring the highest quality of clinical data management.

Nikola holds an M.D. in medicine from the University of Belgrade, Serbia, with a specialization in radiation oncology from the University of Berne, Switzerland.

Steven Bukvic

Steven Bukvic graduated from Coventry University in 1982 with a degree in Applied Biology. After serving in the commercial sector of the UK motor industry for 8 years, Steven joined the Pharmaceutical Industry in 1990. For the next 27 years Steven’s career in the Pharmaceutical / CRO sectors has covered a broad range of disciplines within the field of clinical research, including clinical site monitoring, project management, pharmacovigilance, training, quality assurance and business operations. Steven has worked in Covance, GSK, MSD and Pfizer to name just a few of the multi-national companies in his career. Steven was instrumental in establishing a CRO in Asia as well as successfully building a number of CRO partnerships. He has also had extensive geographical exposure having worked in the UK, US, Germany, China and the Russian Federation.

Dr. Jawad Gill

Dr Gill brings over 27 years of experience at leading Pharma companies and CROs across Pakistan, APAC, AME, and CIS. He is a medical graduate, and his expertise covers several facets of clinical research including Clinical Operations, Quality Assurance & Compliance, Medical Monitoring, and Training. Over his career, he has successfully led global teams in various functions.

Dr Gill brings over 27 years of experience at leading Pharma companies and CROs across Pakistan, APAC, AME, and CIS. He is a medical graduate, and his expertise covers several facets of clinical research including Clinical Operations, Quality Assurance & Compliance, Medical Monitoring, and Training. Over his career, he has successfully led global teams in various functions.

Eventually he moved on to GSK Singapore as Clinical Research, Quality and Training Manager, where he managed teams across Asia-Pacific, Middle East, Africa, and Central Asian regions. During this time, he developed, trained, and led Clinical Operations country teams in Singapore, Malaysia, and Vietnam.

In his most recent role at Fortrea (previously known as Covance) Singapore, as Head of Clinical QA&C he managed Southeast Asia, Japan, South Korea, Australia, and New Zealand, leading a team of auditors conducting Investigator Site Audits, Process Audits, Vendor Qualification Audits, and supporting Client Audits and Regulatory Inspections.

Dr Gill has held leadership positions in various functions, organizations, and regions and has developed, trained, and led several teams simultaneously. Overall, he has been actively involved in more than 150 clinical studies with different phases, designs, and complexities. He has conducted trainings for clinical research professionals and investigators in Pakistan, China, Taiwan, Philippines, S. Korea, S. Africa, Thailand, Vietnam, Turkey and several other countries. He has been involved in the formulation of clinical research guidelines and regulations in some developing countries.

Denise McNerney

With over 25 years of expertise in Business, Marketing, and Technology within the life sciences industry, Denise is a seasoned professional. Her entrepreneurial drive, coupled with vast knowledge and resources, has fueled the creation of multiple successful businesses, streamlined processes, and fostered cohesive teams. Throughout her career, Denise has been instrumental in the launch of innovative products and services, effectively reaching targeted audiences. Building on a foundation of trust, she has cultivated enduring business relationships.

As a Partner at Global Life Sciences Alliance, Denise channels her skills into business development, strategy, and operations. Beyond her professional endeavors, Denise finds joy in volunteering for nonprofits, mentoring individuals and advising startup companies. An avid traveler and enthusiast of an active lifestyle, she embraces diverse experiences in both her personal and professional spheres.

Charles Oviawe

Charles is a Quality Assurance professional with over 20 year’s experience in Quality Systems Development and Management with emphasis on the United States Food and Drug Administration, ICH and global requirements for Good Clinical Practices, Good Laboratory Practice for Nonclinical Laboratory Studies, Good Pharmacovigilance Practices, Clinical Laboratory Improvement Amendments, current Good Manufacturing Practices and Computer System Validation.

Georges Labaki

Georges Labaki obtained his Pharm D in 2000 from Saint Joseph University in Lebanon. In addition, he holds a Master’s Degree in Cardiovascular Pharmacology from Claude-Bernard University, Lyon, France and an executive MBA from Ecole Supérieure des Affaires, Lebanon. Dr Labaki developed 18 years of professional experience in clinical research from big pharmaceutical companies and CROs in Lebanon and Switzerland, such as Merck Serono, Sanofi, Quintiles Outcome and ClinTec International.

Starting October 2012, Dr Labaki became the Chief Executive Officer of his own Clinical Research Organization (CRO): Phoenix Clinical Research (Phoenix CR); with main focus on the Middle East and North Africa region.

He is also the Co-Founder of Balsam Clinical Research, that started operations in Saudi Arabia in October 2021.

Kálmán Törőcsik

Kálmán Törőcsik graduated from University of Szeged in 2005 as doctor of medicine. Since his graduation Kálmán serves the Pharmaceutical Industry. Working with different Pharmaceutical and CRO companies like Amgen, Allergan, Pfizer and Chiltern Kalman collected experience on several fields of clinical research operation as CRA and project manager. Starting March 2014, as a joint partner, Kalman became the Chief Operating Officer of Research Professionals Ltd., a Hungarian CRO with main focus on Central European Region. In this position his is responsible for conducting of clinical trials and home care services in the region.

Mariano Monteagudo

With over 14 years of experience in pharmacology and clinical research, he currently leads the business development and customer relations efforts at Activa-CRO, focused on finding the best solution for project success from regulatory, operational and financial perspectives. Mr. Monteagudo received both his Pharmacist and MBA at Pontificia Universidad Catòlica (UCA) Buenos Aires, ARG, and has held a range of positions of increasing responsibility in the CRO industry, including experience in Quintiles, Merck Sharpe & Dohme Laboratory (MSD), GSK Pharmaceutical, MDS Pharma Services, MDS Pharma Services, INC Research and I3. Joining Activa in 2013, he worked as CTM as well as interacting with clinical operation planning and customer relations with Biotechs, Pharmaceutical company and CROS and his new position since 2015 as Director Business Development Strategy in which he acts as primary contact of client from US, Europe and Asia due in order to develop and stablish a project in the following Latin America countries: Argentina, Chile, Uruguay, Brazil, Peru, Colombia, Panama, Ecuador and Mexico.

Nikola Cihoric

Nikola is the founder and the innovative mind behind Wemedoo AG.

With over 15 years of experience in radiation oncology at Switzerland’s largest university hospital, he has garnered a reputation as a visionary in the industry. Nikola’s involvement in various international working groups, such as mCODE, CodeX, HL7/FHIR, CDISC, and DIA Europe, reflects his dedication to advancing clinical data standards, driving innovation, and ensuring the highest quality of clinical data management.

Nikola holds an M.D. in medicine from the University of Belgrade, Serbia, with a specialization in radiation oncology from the University of Berne, Switzerland.